These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 15700953)

  • 41. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aminoglycoside resistance genes sgm and kgmB protect bacterial but not yeast small ribosomal subunits in vitro despite high conservation of the rRNA A-site.
    Tomic TI; Moric I; Conn GL; Vasiljevic B
    Res Microbiol; 2008; 159(9-10):658-62. PubMed ID: 18930134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.
    Ding Y; Hofstadler SA; Swayze EE; Risen L; Griffey RH
    Angew Chem Int Ed Engl; 2003 Jul; 42(29):3409-12. PubMed ID: 12888972
    [No Abstract]   [Full Text] [Related]  

  • 44. Kosinostatin, a major secondary metabolite isolated from the culture filtrate of Streptomyces violaceusniger strain HAL64.
    El-Naggar MY
    J Microbiol; 2007 Jun; 45(3):262-7. PubMed ID: 17618233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA.
    Simonsen KB; Ayida BK; Vourloumis D; Takahashi M; Winters GC; Barluenga S; Qamar S; Shandrick S; Zhao Q; Hermann T
    Chembiochem; 2002 Dec; 3(12):1223-8. PubMed ID: 12465030
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Lee TH; Hwang JH; Lee WK; Shin MK; Woo HR; Chung KM; Lee CS
    J Korean Med Sci; 2018 Oct; 33(42):e262. PubMed ID: 30310364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new class of branched aminoglycosides: pseudo-pentasaccharide derivatives of neomycin B.
    Fridman M; Belakhov V; Yaron S; Baasov T
    Org Lett; 2003 Oct; 5(20):3575-8. PubMed ID: 14507176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rigid spiroethers targeting the decoding center of the bacterial ribosome.
    Mavridis I; Kythreoti G; Koltsida K; Vourloumis D
    Bioorg Med Chem; 2014 Feb; 22(4):1329-41. PubMed ID: 24457095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gram-negative bacterial resistance: evolving patterns and treatment paradigms.
    Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S85-8. PubMed ID: 15712101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria.
    Pagès JM; James CE; Winterhalter M
    Nat Rev Microbiol; 2008 Dec; 6(12):893-903. PubMed ID: 18997824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
    Zimmermann L; Bussière A; Ouberai M; Baussanne I; Jolivalt C; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2013 Oct; 56(19):7691-705. PubMed ID: 24083676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New plasmid-mediated resistances to antimicrobial agents.
    Courvalin P
    Arch Microbiol; 2008 Apr; 189(4):289-91. PubMed ID: 18094959
    [No Abstract]   [Full Text] [Related]  

  • 53. A detailed study of antibacterial 3-acyltetramic acids and 3-acylpiperidine-2,4-diones.
    Jeong YC; Bikadi Z; Hazai E; Moloney MG
    ChemMedChem; 2014 Aug; 9(8):1826-37. PubMed ID: 24838989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in developing small molecules targeting RNA.
    Guan L; Disney MD
    ACS Chem Biol; 2012 Jan; 7(1):73-86. PubMed ID: 22185671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Isolation of antibiotic resistance bacterial strains from East Siberia permafrost sediments].
    Mindlin SZ; Soina VS; Ptrova MA; Gorlenko ZhM
    Genetika; 2008 Jan; 44(1):36-44. PubMed ID: 18409385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmid-mediated 16S rRNA methylases among extended-spectrum-beta-lactamase-producing Salmonella enterica Senftenberg isolates from Algeria.
    Naas T; Bentchouala C; Lima S; Lezzar A; Smati F; Scheftel JM; Nordmann P
    J Antimicrob Chemother; 2009 Oct; 64(4):866-8. PubMed ID: 19700474
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site.
    Barbault F; Ren B; Rebehmed J; Teixeira C; Luo Y; Smila-Castro O; Maurel F; Fan B; Zhang L; Zhang L
    Eur J Med Chem; 2008 Aug; 43(8):1648-56. PubMed ID: 18096272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic blocks mRNA path on the ribosome.
    Mankin A
    Nat Struct Mol Biol; 2006 Oct; 13(10):858-60. PubMed ID: 17021617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.